» Articles » PMID: 21343881

Possible Involvement of Complement Factor C1q in the Clearance of Extracellular Neuromelanin from the Substantia Nigra in Parkinson Disease

Overview
Specialties Neurology
Pathology
Date 2011 Feb 24
PMID 21343881
Citations 51
Authors
Affiliations
Soon will be listed here.
Abstract

Activation of the complement system promotes the removal of pathogens and tissue damage products from the brain and may also be involved in neuronal cell death in neurodegenerative diseases. Here, we analyzed the expression of C1q, the initial recognition subcomponent of the classic complement cascade, in the substantia nigra pars compacta (SNc) in Parkinson disease (PD) and control cases using immunohistochemistry and in situ hybridization. Microglia were determined to be the only cells that expressed C1q in the SNc and other brain areas. In the SNc of PD cases, there was increased deposition of extracellular neuromelanin in the parenchyma, resulting from degeneration of dopaminergic neurons. Neuromelanin granules and blebs of degenerated neurons seemed to be opsonized by C1q and phagocytosed by C1q-positive microglia and macrophages in the parenchyma and in the perivascular spaces. Neuromelanin-laden C1q-positive cells were also attached to the luminal surfaces of blood vessels in the SNc in PD. Thus, we present evidence suggesting that microglia are capable of phagocytosing and clearing cellular debris of degenerating neurons from the SNc through a C1q-mediated pathway in PD.

Citing Articles

The complement system in neurodegenerative and inflammatory diseases of the central nervous system.

Negro-Demontel L, Maleki A, Reich D, Kemper C Front Neurol. 2024; 15:1396520.

PMID: 39022733 PMC: 11252048. DOI: 10.3389/fneur.2024.1396520.


Organelle phenotyping and multi-dimensional microscopy identify C1q as a novel regulator of microglial function.

Sakthivel P, Scipioni L, Karam J, Keulen Z, Blurton-Jones M, Gratton E J Neurochem. 2024; 168(9):3095-3107.

PMID: 39018376 PMC: 11449638. DOI: 10.1111/jnc.16173.


Selective dopaminergic neurotoxicity modulated by inherent cell-type specific neurobiology.

Currim F, Tanwar R, Brown-Leung J, Paranjape N, Liu J, Sanders L Neurotoxicology. 2024; 103:266-287.

PMID: 38964509 PMC: 11288778. DOI: 10.1016/j.neuro.2024.06.016.


Spatial transcriptomics reveals molecular dysfunction associated with cortical Lewy pathology.

Goralski T, Meyerdirk L, Breton L, Brasseur L, Kurgat K, DeWeerd D Nat Commun. 2024; 15(1):2642.

PMID: 38531900 PMC: 10966039. DOI: 10.1038/s41467-024-47027-8.


The complement system in neurodegenerative diseases.

Nimmo J, Byrne R, Daskoulidou N, Watkins L, Carpanini S, Zelek W Clin Sci (Lond). 2024; 138(6):387-412.

PMID: 38505993 PMC: 10958133. DOI: 10.1042/CS20230513.